| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |